Success Stories: Associate Research Scientist in Connecticut in the Field of Molecular Biology and Genetics Has EB-1A Approved

Client’s Testimonial:

 

I am very glad that my case can be approved so soon.[…] I already recommended wegreened to a few friends of mine […] Thanks again for the professional service that wegreened provided.
 


On July 29th, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for an Associate Research Scientist in the Field of Molecular Biology and Genetics (Approval Notice)


General Field: Molecular Biology and Genetics

Position at the Time of Case Filing: Associate Research Scientist

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing:  Connecticut

Approval Notice Date: July 29, 2014

Processing Time: 2 months, 23 days (11 days after requesting Premium Processing)

 


Case Summary:

In this case, the client that we had the opportunity to work was an Associate Research Scientist from China in the field of Molecular Biology and Genetics.  His specialized research had focused on structural and functional studies of macromolecules.  His work had resulted in 11 peer-reviewed scientific articles and 12 presentations at national and international conferences.  At the time that his case was filed, his publications had been cited at least 207 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work.  He had also reviewed 30 manuscripts for distinctive, internationally-circulated journals related to his field.  The importance of his work was confirmed in the following quote from an independent recommender, “These methodologies used in [his] research have implications for clinical approaches as well, helping to design new antibiotics based on fundamental information gathered concerning the transcription process. With the heightened ability to specifically bind RNAP and thereby control gene expression, development of targeted therapies for countless bacterial infections can be undertaken. There is no doubt that [he] possesses a profound knowledge surrounding his subject of interest, and it would be highly beneficial to the United States research community as a whole to allow him to continue his stellar research.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought remain in the United States to continue work in the area of extraordinary ability, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 2 months and 23 days.